Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuv (Q38464308)
Jump to navigation
Jump to search
scientific article published on April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuv |
scientific article published on April 2011 |
Statements
1 reference
Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuv (English)
1 reference
Paul M Ridker
1 reference
Judith Hsia
1 reference
Jean G MacFadyen
1 reference
John Monyak
1 reference
1 April 2011
1 reference
1 reference
Identifiers
1 reference